Wedbush Securities Inc Moon Lake Immunotherapeutics Transaction History

Wedbush Securities Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$36.35 - $63.02 $11,959 - $20,733	329 Added 7.97%	4,455 $269,000
Q3 2023 Nov 14, 2023	SELL	$48.35 - $61.26 $133,639 - $169,322	-2,764 Reduced 40.12%	4,126 $235,000
Q2 2023 Aug 14, 2023	BUY	$19.01 - $51.79 $130,978 - $356,833	6,890 New	6,890 $351,000

124

58.2M

52.2K

38K

Ticker MLTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,925,600
Market Cap $2.01B
Description
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.